Long COVID affects about 6.9% of adults, according to the CDC, and women are slightly more likely than men to get it. In June, a Stanford (Calif.) Medicine study of 155 patients with moderate to severe COVID found that taking Paxlovid for 15 days was safe, but didn’t reduce symptoms of long COVID.
But a study published Jan. 6 in Communications Medicine found Paxlovid could help some patients. The study had 13 patients with long COVID take Paxlovid for seven to 30 days. The results were mixed: Nine patients reported improvement, but only five said it lasted, while four reported no improvement at all.
So far, there has been no widely effective treatment found for long COVID.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.